Bridgeway Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Buy |
+95,000
| New | +$354K | 0.01% | 834 |
|
|
2023
Q4 | – | Sell |
-27,500
| Closed | -$138K | – | 1415 |
|
|
2023
Q3 | $138K | Sell |
27,500
-23,200
| -46% | -$117K | ﹤0.01% | 1164 |
|
|
2023
Q2 | $444K | Hold |
50,700
| – | – | 0.01% | 934 |
|
|
2023
Q1 | $600K | Sell |
50,700
-42,000
| -45% | -$497K | 0.02% | 843 |
|
|
2022
Q4 | $944K | Buy |
92,700
+23,200
| +33% | +$236K | 0.02% | 743 |
|
|
2022
Q3 | $409K | Buy |
69,500
+24,000
| +53% | +$141K | 0.01% | 944 |
|
|
2022
Q2 | $113K | Sell |
45,500
-17,200
| -27% | -$42.7K | ﹤0.01% | 1207 |
|
|
2022
Q1 | $186K | Sell |
62,700
-32,800
| -34% | -$97.3K | ﹤0.01% | 1184 |
|
|
2021
Q4 | $675K | Buy |
+95,500
| New | +$675K | 0.01% | 898 |
|